GS
CMRAW

GTS Securities’s Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 CMRAW Stock Holding History

GTS Securities’s Portfolio CMRAW Stock Details CMRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-11,494
Closed -$207 – 4537
2023
Q3 		$207 Sell
11,494
-100
-0.9% -$3 ﹤0.01% 3883
2023
Q2 		$348 Buy
+11,594
New +$386 ﹤0.01% 1207

Other funds holding CMRAW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

GTS Securities's CMRAW Position: Q4 2023 in Review

GTS Securities sold out of Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 (CMRAW) in Q4 2023, closing a stake of 11,494 shares — an estimated $207 sold.

GTS Securities first reported a position in CMRAW in Q2 2023 and held it in 2 quarters. The position peaked at $348 in Q2 2023. 3 funds tracked by Wall St. Rank hold CMRAW as of Q4 2023.

  • GTS Securities reported no remaining Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 position as of Q4 2023 after selling out during the quarter.
  • GTS Securities sold 11,494 Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 shares in Q4 2023, an estimated $207.
  • GTS Securities first reported a position in Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 in Q2 2023 and held it in 2 quarters.
  • GTS Securities's Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 position peaked at $348 in Q2 2023.
  • 3 funds tracked by Wall St. Rank held Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 as of Q4 2023.

Based on GTS Securities's 13F filing for Q4 2023, filed 15 Feb 2024.